why choose us

Clinical Trials Search

Showing 14,520 of 132,656 result(s)
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Status: Completed

Condition: Chronic Idiopathic Urticaria

Interventions: ADL-018 (Omalizumab) solution for injection 150 mg;mL prefilled syringe (PFS)

Date: 2023-02-25

Barbed-suture Efficiency Study for Sacrocolpopexy

Status: Completed

Condition: Prolapse; Female

Interventions: The non-barbed delayed absorbable suture group vaginal mesh attachment will be performed with 2-0 PDS (polydioxanone).
The vaginal mesh will be a

Date: 2023-02-25

Endometrial Biopsy in Progestin Contraceptive Users

Status: Completed

Condition: Contraception

Interventions: The participant will receive the contraceptive injectable, Depo-Provera at the enrollment visit and at 3, 6, 9, and 12 months.
Participants will

Date: 2023-02-25

Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS;BRAF Wild-type Metastatic Colorectal Cancer

Status: COMPLETED

Condition: Metastatic Colorectal Cancer

Interventions: Cetuximab will be given triweekly at a dose from 400mg;m2 to 700mg;m2.

Date: 2023-02-25

A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects with Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

Status: COMPLETED

Condition: Hypertension

Interventions: Placebo once daily for 12 weeks

Date: 2023-02-24

Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

Status: Completed

Condition: Acute Kidney Injury

Interventions:

The Selective Cytopheretic Device (SCD) is comprised of tubing, connectors, and a synthetic hollow fiber membrane cartridge.
The device is con

Date: 2023-02-24

A Study to Compare the Efficacy, Safety and Tolerability of FF;UMEC;VI With FF;VI in 12-17-year-olds With Asthma

Status: Completed

Condition: Asthma

Interventions: FF;UMEC;VI will be administered.

Date: 2023-02-24

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression

Status: Completed

Condition: Depression

Interventions: Individual alpha tACS

Date: 2023-02-24

Study of Dotatate Imaging in Breast Cancer

Status: ACTIVE_NOT_RECRUITING

Condition: Breast Cancer Stage IV

Interventions: Gallium-68 DOTATATE is a diagnostic agent for use with positron emission tomography (PET) for localization of somatostatin receptor expression on tumo

Date: 2023-02-24

A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer

Status: Completed

Condition: Esophageal Carcinoma

Interventions:

Date: 2023-02-24